This is a poster from the recent ATA conference (no 125). I can't get the actual poster but what it says is:
A recent multicenter, double-blind randomized clinical trial (presented @AmThyroidAssn meeting) involved 284 patients and compared therapy with LT4 vs desiccated thyroid extract (DTE) for up to 48 weeks. Overall safety and adverse events were similar in both groups.
There are also similar large trials being conducted in the Netherlands and the UK.
Written by
diogenes
Remembering
To view profiles and participate in discussions please or .
Great news! I hope they're continuing the study for longer than 48 weeks, because we can imagine the doubters questioning the validity of a study of that duration. But another tick in the box 👍
Yes, I still worry about the design of the trials. Insofar as if adequate dosing is, on both the T4 and the NDT arms defined by TSH in the reference range as the determination factor for proper dosing.
Exactly - if having a TSH in range is a ' given ' there is no point - and it's just another contrived stitch up and a salary for certain people - but I couldn't possible say or comment further !!
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.